Strategic management of innovation risk in the biopharmaceutical industry: a UK perspective

Author： Chandrasekar C.R.   Helliar C.V.   Lonie A.A.   Nixon W.A.   Power D.M.  

Publisher： Inderscience Publishers

ISSN： 1368-2156

Source： International Journal of Healthcare Technology and Management, Vol.1, Iss.1-2, 2003-06, pp. : 62-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory Innovation in Postmarketing Risk Assessment and Management

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 555-557

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biopharmaceutical industry perspectives on the business prospects for personalized medicine

By Milne Christopher-Paul   Zuckerman Rachael  

Personalized Medicine, Vol. 8, Iss. 5, 2011-09 ,pp. : 541-550

Future Medicine

Access to resources Recommend Favorite

Risk Management and Injury Prevention: Competencies, Behaviours, and Attitudes to Safety in the Construction Industry

By  

Australian Journal of Rehabilitation Counselling, Vol. 13, Iss. 2, 2007-09 ,pp. : 63-67

Cambridge University Press

Access to resources Recommend Favorite

Innovation in the medical device industry

By Merode Godefridus G. van   Adang Eddy M.M.   Paulus Aggie T.G.  

International Journal of Healthcare Technology and Management, Vol. 4, Iss. 5, 2003-07 ,pp. : 333-349

Inderscience Publishers

Access to resources Recommend Favorite

Patent Ductus Arteriosus

By  

CONGENITAL HEART DISEASE, Vol. 10, Iss. 1, 2015-01 ,pp. : 86-87

John Wiley & Sons Inc

Access to resources Recommend Favorite